The Jon Fland City Council held an informal meeting on June 2, 2025, from 5:15 PM to approximately 5:57 PM. The sole agenda item was the semi-annual insurance update presented by Siegel, the city's consultant. The presentation covered the 2024 budget-to-actual financial report, first-quarter 2025 data, and the results of a comprehensive request for proposals (RFP) process for all lines of insurance (dental, vision, life, disability, medical, and prescription drugs). Key recommendations were made for vendor selections and benefit changes, with savings projected for the city and employees.
Good evening, everyone. Welcome to the informal meeting of the Jon Fland City Council. It is 5 15 p.m. on June 2nd, 2025. Our first item on the agenda is the semi-annual insurance update by Siegel. Good evening, Mrs. Haas. Good evening, Mayor. Council. Every five years, the city goes to bid for all lines of our health related insurance through our consultant Siegel. So health insurance, dental insurance, vision, life, disability. And this is our year to do that for coverage starting January 1st of 26th. So tonight, Kim Wixon, and Brian Hunter Hunter is back here. We'll cover the normal budget to actual report and then the recommendations and next steps from the from the bid process. Oh there they are. I'd like to see the slide in the back. We'll get it going here in a minute. We're from the country. It takes us a minute to get things going. Thank you. Well, good evening and welcome. We're glad that you're here. Look forward to your report. Yeah, well, thank you for having me. And I think we have I'm I'm I'm very pleased with the report we're going to give you today. Um, actually, all of the reports, but we're gonna start off with the preliminary budget to actual report, which we give every year at this time, and we go over the 2024 uh calendar year, and then what we've seen for the first quarter in 2025 to kind of give a preview of maybe what to expect when we give the final um budget report, usually in the October time frame. I'm going to go over this a little bit more quickly because I want to make sure we have enough time because we have all the RFPs to go through, and I want to make sure we have time for questions as well. But we do have pretty good news on slide three. This actually includes our um the 2024 financial statement on a cash basis. So this is mean when bills are presented, um, that's when they're included in this report. Um, and you can see from our contributions, they've remained pretty consistent throughout the year. We've seen some uptick. We did have some growth in the number of employees, so did expect that to increase a little bit. Um in December, you can see it's a little bit lower, and that's just because the last contribution payroll contribution for the last payroll, you'll see that reflected in the January report. So that's why it's a little bit lower. It's just where it's like uh where it had been accounted for. Um, on our medical claims, they were also pretty consistent. You can see we had a fairly major dip in May, um, but then we had a subsequent um increase in June. Sometimes when claims, if we had a big claim that uh was readjudicated, we may see a credit in one month and then see the readjudication of that claim in the previous month. But overall, it's been fairly consistent. Uh on our stop loss reimbursements. We did have reimbursements in the first part of this year, and what that um generally is for are for actual claims that were paid in the previous year, but late in the year in November or December. So then when we actually get those credits coming through, they usually come through in the following in the following year. Uh but you can see we also had some credits coming through in October, November, and December, and those were for claims that were paid in the 2024 um calendar year. Prescription drugs um are pretty consistent as well. Sometimes you'll see some fluctuations. We are billed prescription drug claims on a bi-weekly basis. So a couple months a year, sometimes you see a little bit of an increase because it's that third um biweekly payment in that particular month, but we've seen those um pretty consistent, but those have been gradually um increasing over time. On the prescription drug rebates, these are actually um, we've actually seen some increases as we're moving into the year, and as we go into the RFP in terms of our projections, we are actually um our guarantees are increasing quite a bit. So we should see an increase in those in those prescription drug rebates over time, and that actually offsets the cost of your prescription drug claims, are those uh prescription drug rebates.